NCT00314119 2026-03-11
Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
National Institutes of Health Clinical Center (CC)
Completed
Clinical Trials
9 trialsNCT00924196 2026-03-09
Natural History Study of Patients With Neurofibromatosis Type I
National Institutes of Health Clinical Center (CC)
Active not recruiting
NCT00111384 2026-02-17
Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
National Institutes of Health Clinical Center (CC)
Completed
NCT07298083 2025-12-23
DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins
M.D. Anderson Cancer Center
Not yet recruiting
NCT05581511 2025-10-14
cNF Natural Hx
Johns Hopkins University
Active not recruiting
NCT06880991 2025-10-06
Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study
National Institutes of Health Clinical Center (CC)
Recruiting
NCT06222203 2025-09-26
Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
National Institutes of Health Clinical Center (CC)
Recruiting
NCT05238909 2025-09-02
Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1
Ann & Robert H Lurie Children's Hospital of Chicago
Enrolling by invitation
NCT05891847 2025-06-10
Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia
AstraZeneca
Active not recruiting